Table 2.
Laboratory values changes between Time from Day 0 (T0) and Time from Day Five (T5) in patients treated with Molnupiravir.
| Laboratory Value | T0 | T5 | Wilcoxon Test * |
|---|---|---|---|
| AST (UI/L) | 49.88 (9–296) | 41.3 (15–157) | 0.737 |
| ALT (UI/L) | 36.12 (3–254) | 29.02 (9–110) | 0.522 |
| Creatinine (mg/dL) | 1.05 (0.38–2.5) | 0.97 (0.39–1.9) | 0.128 |
| WBC (total count) | 6676 (2500–18,930) | 9201 (3120–65,330) | 0.501 |
| Lymphocyte (absolute count) | 1149 (340–2450) | 3500 (510–57,490) | 0.081 |
| Monocyte (absolute count) | 639 (270–1410) | 546.67 (230–580) | 0.048 |
| Eosinophile (absolute count) | 150(0–560) | 127(0–810) | 0.394 |
| PLTS (absolute count) | 189(0.112–400) | 221 (0.243–479) | 0.162 |
Abbreviations: AST: aspartate aminotransferase; ALT: alanine aminotransferase; WBC: white blood cell; PLTS: platelets; T0: time from Day 0; T5: time from day 5. * Data were entered and analysed using SPSS® version 27.0 (IBM®).